Cheng H Lee

Title: Innovations of Cheng H Lee

Introduction

Cheng H Lee is a notable inventor based in Singapore, recognized for his contributions to the field of pharmaceuticals. He holds a total of three patents, showcasing his innovative approach to medical treatments.

Latest Patents

One of his latest patents is for a compound described as (9E)-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2.5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt. This invention relates to certain salts of this compound, which have been found to exhibit improved properties. Specifically, it pertains to the citrate salt of the compound and includes pharmaceutical compositions containing this salt, along with methods for its use in treating various medical conditions. Another significant patent is for 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate salt. This invention also focuses on certain salts of the compound, particularly the maleate salt, and discusses its pharmaceutical applications and methods of use in medical treatments.

Career Highlights

Cheng H Lee is currently associated with Cti Biopharma Corp., where he continues to innovate in the pharmaceutical sector. His work has significantly contributed to advancements in drug formulations and therapeutic applications.

Collaborations

He collaborates with notable colleagues, including Brian William Dymock and Anthony Deodaunia William, enhancing the research and development efforts within his field.

Conclusion

Cheng H Lee's innovative work in pharmaceuticals, particularly through his recent patents, highlights his commitment to improving medical treatments. His contributions are valuable to the ongoing advancements in healthcare.